SK Biopharmaceuticals Co., Ltd. (326030.KS)

KRW 103600.0

(-2.54%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 723.17 Billion 664.24 Billion 643.65 Billion 500.24 Billion 139.07 Billion 95.53 Billion
Total Current Assets 488.72 Billion 487.92 Billion 471.21 Billion 434.6 Billion 98.68 Billion 81.55 Billion
Cash And Short Term Investments 241.11 Billion 305.45 Billion 334.33 Billion 387.99 Billion 82.37 Billion 76.52 Billion
Cash and Cash Equivalents 239.7 Billion 104.05 Billion 225.92 Billion 59.33 Billion 51.14 Billion 74.29 Billion
Short Term Investments 1.41 Billion 201.39 Billion 108.41 Billion 328.65 Billion 31.23 Billion 2.23 Billion
Net Receivables 115.84 Billion 89.01 Billion 83.59 Billion 12.63 Billion 9.35 Billion 4.82 Billion
Inventory 102.52 Billion 90.91 Billion 51.93 Billion 23.03 Billion 6.73 Billion 162.28 Million
Other Current Assets 29.23 Billion 2.53 Billion 1.35 Billion 10.93 Billion 222.55 Million 38.69 Million
Total Non-Current Assets 234.44 Billion 176.31 Billion 172.43 Billion 65.63 Billion 40.39 Billion 13.97 Billion
Net PPE 47.75 Billion 20.34 Billion 22.93 Billion 24.23 Billion 25.89 Billion 12.15 Billion
Good Will And Intangible Assets 27.02 Billion 17.18 Billion 18.89 Billion 19.69 Billion 883.31 Million 245.97 Million
Good Will 3.39 Billion - - - - -
Intangible Assets 23.63 Billion 17.18 Billion 18.89 Billion 19.69 Billion 883.31 Million 245.97 Million
Long-Term Investments 104.17 Billion -101.43 Billion -752.46 Million -321.8 Billion -31.22 Billion -2.18 Billion
Tax Assets 44.72 Billion 29.64 Billion 18.91 Billion 11.83 Billion 13.55 Billion 2.23 Billion
Other Non Current Assets 10.77 Billion 210.58 Billion 112.42 Billion 331.68 Billion 31.28 Billion 1.52 Billion
Other Assets 1.00 - - -10.00 - -
Total Liabilities 402.21 Billion 347.68 Billion 199.46 Billion 121.17 Billion 152.09 Billion 36.9 Billion
Total Current Liabilities 241.61 Billion 163.07 Billion 148.3 Billion 70.59 Billion 145.64 Billion 30.97 Billion
Account Payables 2.34 Billion 23.1 Billion 16.93 Billion 8.95 Billion - -
Tax Payables 88.78 Million 208.35 Million 1.99 Billion - - -
Short Term Debt 57.06 Billion 5.64 Billion 5.48 Billion 4.9 Billion 103.19 Billion -
Deferred Revenue 33.86 Billion 30.84 Billion 125.78 Billion 56.63 Billion - 848.07 Million
Other Current Liabilities 148.34 Billion 103.47 Billion 107.33 Million 105.78 Million 42.44 Billion 30.12 Billion
Total Non Current Liabilities 160.6 Billion 184.6 Billion 51.15 Billion 50.57 Billion 6.45 Billion 5.93 Billion
Long-Term Debt 94.48 Billion 150.25 Billion 10.25 Billion 13.57 Billion 5.85 Billion -
Deferred Revenue Non Current 11.99 Billion 31.15 Billion 38.58 Billion 35.04 Billion - 1.46 Billion
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 52.21 Billion 3.19 Billion 400.00 -20.00 599.29 Million 4.46 Billion
Other Liabilities - - - - - -
Total Equity 320.95 Billion 316.56 Billion 444.18 Billion 379.06 Billion -13.02 Billion 58.62 Billion
Stock Holders Equity 283.68 Billion 316.56 Billion 444.18 Billion 379.06 Billion -13.02 Billion 58.62 Billion
Common Stock 39.15 Billion 39.15 Billion 39.15 Billion 39.15 Billion 32.5 Billion 32.5 Billion
Retained Earnings -848.31 Billion -827.55 Billion -689.14 Billion -746.95 Billion -498.94 Billion -426.4 Billion
Accumulated other comprehensive income 8 Billion 8.29 Billion 9.32 Billion 2.01 Billion 7.38 Billion 6.49 Billion
Common Stock Equity 283.68 Billion 316.56 Billion 444.18 Billion 379.06 Billion -13.02 Billion 58.62 Billion
Capital Lease Obligation 26.5 Billion 12.17 Billion 15.73 Billion 18.47 Billion 9.05 Billion -
Total Investments 105.59 Billion 99.95 Billion 107.66 Billion 6.84 Billion 7 Million 47.69 Million
Total Debt 178.05 Billion 155.89 Billion 15.73 Billion 18.47 Billion 109.05 Billion -
Net Debt -61.64 Billion 51.83 Billion -210.18 Billion -40.85 Billion 57.91 Billion -74.29 Billion

Balance Sheet Charts